Search

Your search keyword '"myelodysplastic syndrome"' showing total 423 results

Search Constraints

Start Over You searched for: Descriptor "myelodysplastic syndrome" Remove constraint Descriptor: "myelodysplastic syndrome" Database Directory of Open Access Journals Remove constraint Database: Directory of Open Access Journals
423 results on '"myelodysplastic syndrome"'

Search Results

1. Eosinophilia with STAT5BN642H Mutation: A Heterogeneous Entity with Overlapping Morphological Features and Poor Outcome

2. Effects of PTPN6 Gene Knockdown in SKM-1 Cells on Apoptosis, Erythroid Differentiation and Inflammations

3. Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome

4. Landscape of biallelic DNMT3A mutant myeloid neoplasms

5. Higher prevalence of poor prognostic markers at a younger age in adult patients with myelodysplastic syndrome – evaluation of a large cohort in India

6. Ultralow-dose irradiation enables engraftment and intravital tracking of disease initiating niches in clonal hematopoiesis

7. Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study

8. Low Levels of Natural Killer Cell in Newly Diagnosed Myelodysplastic Syndromes Patients May Confer Poor Prognosis: A Retrospective Cohort Study

9. Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma

10. Iron overload impact on peripheral blood cells, lymphocytes and karyotypes in newly diagnosed myelodysplastic syndromes (MDS) patients: a single-center retrospective analysis

11. Variation characteristics and clinical significance of TP53 in patients with myeloid neoplasms

12. Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from MDS patients

13. Case report: VEXAS syndrome and literature review

14. COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)

15. The consensus on the diagnosis and treatment of elderly myelodysplastic neoplasm in China (2024)

16. Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome Associated with 20q Deletion

17. HALP score as a novel prognostic factor for patients with myelodysplastic syndromes

18. Effects of immune cells in mediating the relationship between gut microbiota and myelodysplastic syndrome: a bidirectional two-sample, two-step Mendelian randomization study

19. Haemophagocytic lymphohistiocytosis caused by GATA2 deficiency: a report on three patients

20. A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms

21. High PD-L1 expression is associated with unfavorable clinical features in myelodysplastic neoplasms

22. Comparative analysis of feature-based ML and CNN for binucleated erythroblast quantification in myelodysplastic syndrome patients using imaging flow cytometry data

23. Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape

24. Molecular genetic characterization of myeloid neoplasms with idic(X)(q13) and i(X)(q10)

25. Impact of platelet transfusion refractoriness in the first 30 days post-hematopoietic stem cell transplantation on outcomes of patients with myelodysplastic syndrome

26. Immune‐dysregulation harnessing in myeloid neoplasms

27. Acquired erythropoietic protoporphyria secondary to myelodysplastic syndrome: from mythology to oncologyAcquired Erythropoietic Protoporphyria Secondary to Myelodysplastic Syndrome: From Mythology to Oncology

28. Trisomy 8 presentation by inflammatory manifestations and its response to thalidomide: two case reports and narrative review

30. Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review

31. Angioinvasive Mucormycosis Mimicking Mass and Pulmonary Thromboembolism in a Patient with Myelodysplastic Syndrome: A Case Report

32. Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine

33. MYELODYSPLASTIC SYNDROME NOT OTHERWISE CLASSIFIED. DO AUTOMATIC METHODS CORRELATE WITH THE MICROSCOPIC METHOD OF BLOOD SMEAR ASSESSMENT?

35. Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group

37. Cranial hypertrophic pachymeningitis with myelodysplastic syndrome

38. A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine

39. Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review

40. VEXAS syndrome: on the threshold of changing perceptions of known diseases

41. Features of the clinical picture and course of GATA2 deficiency complicated by generalized verrucosis with an outcome in myelodysplastic syndrome in adulthood

42. TNFα induces Caspase-3 activity in hematopoietic progenitor cells CD34+, CD33+, and CD41 + of myelodysplastic syndromes

43. Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions

44. Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms

45. Refractory Intestinal Behçet-Like Disease Associated with Trisomy 8 Myelodysplastic Syndrome Resolved by Parenteral Nutrition

47. Integrated medical and nursing ward rounds in a patient with myelodysplastic syndrome (医护一体化查房模式下1例骨髓增生异常综合征患者的护理体会)

48. Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome

49. Decitabine/Cedazuridine in the Management of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia in Canada

50. Booster effect of a third mRNA‐based COVID‐19 vaccine dose in patients with myeloid malignancies

Catalog

Books, media, physical & digital resources